Gritstone Bio, Inc., a US-based biotech firm, specializes in producing and distributing cancer care drugs.
Developing cancer drugs that starve tumors by hijacking cancer metabolism. Human trials soon.
Jacobio Pharmaceuticals: A leading biotech firm innovating in cancer, autoimmune, and infectious disease treatments.
Phytoceutica, Inc. develops FDA-approved cancer drugs from traditional Chinese medicine, focusing on quality control and reproducibility.
Immuneering: A biopharmaceutical leader innovating unique medicines for complex diseases like cancer.
Boryung Corp: A global pharmaceutical manufacturer specializing in antibiotics, cancer drugs, and more.
Novita Pharmaceuticals: Developing and providing cancer-treatment drugs since 2010, based in New York.
Elevar Therapeutics: Specializing in innovative cancer drug development for unmet medical needs.
SEngine Precision Medicine innovatively engineers next-gen cancer-targeted drugs.
Somanta Pharmaceuticals develops cancer drugs, holds a license for Sodium Phenylbutyrate, and works on overcoming drug-resistant tumors.
Onkaido Therapeutics develops innovative mRNA cancer drugs to improve patient outcomes.
Remedy Plan: A biotech firm developing pioneering drugs to halt tumor growth and cancer metastasis.
Balto Pharmaceuticals: Innovating in cancer drug research and development.
US-based Tosk OAO, founded in 2005, specializes in generating, transmitting, and distributing electric energy.
Emtora Biosciences, a life science company, develops and commercializes eRapa, a novel prostate cancer drug that also slows aging.
Stelexis: A New York-based company dedicated to transforming cancer care through novel drug development.
CerRx Inc.: Innovating cancer treatment with unique drug discovery and development since 2008.
Black Diamond Therapeutics, a US-based biotech firm, develops precision medicines for genetically-defined cancers.
Innovative cancer and HIV drug developer. Founded in 2005.
Ambagon: Innovating small molecule cancer drugs to stabilize oncogenic proteins interaction.
San Antonio-based Bionumerik Pharmaceuticals designs drugs for cancer treatment and prevention of therapy side effects.
Signet Therapeutics, a biopharmaceutical startup, innovates targeted cancer drugs using unique disease models.
KinoDyn pioneers in cancer drug discovery, leveraging proprietary tech to target challenging cancers.
Mekanistic Therapeutics: Focused on developing innovative cancer drugs.